malaria vaccine


Also found in: Wikipedia.

malaria vaccine

An as-yet hypothetical vaccine against malaria. Development of such a vaccine is extremely difficult given Plasmodium falciparum’s high mutability, in part because it reproduces sexually within the mosquito host, thus maintaining or even increasing its heterozygosity, and because natural immunity to P falciparum requires continued contact with plasmodia to enrich the immune response to the genetically diverse agent, as opposed to the “one-shot” exposure of a vaccine.
References in periodicals archive ?
US-based pharmaceutical packaging, labware, and consumables products company SiO2 Medical Products, Inc and US-based vaccines developer and manufacturer Sanaria Inc have signed an agreement for the development, manufacture, and supply of cryogenic vials for Sanaria's malaria vaccine, Sanaria PfSPZ Vaccine, the companies said.
The worlds first malaria vaccine, RTS,S, has moved a step closer to a global rollout following WHOs announcement that Ghana, Kenya and Malawi will begin administering the vaccine in 2018.
M2 EQUITYBITES-April 24, 2017-Ghana, Kenya and Malawi will pilot GSK's malaria vaccine next year
Johannesburg, Rajab 27, 1438, April 24, 2017, SPA -- The world's first malaria vaccine will be made available in Kenya, Malawi and Ghana starting in 2018, the World Health Organization (WHO) said on Monday, according to dpa.
WASHINGTON, May 9 (KUNA) -- A malaria vaccine has been proven to protect several healthy adults who have never caught the disease for more than one year, the US National Institutes of Health (NIH) said on Monday.
The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it as safe and effective to use in babies in Africa at risk of the mosquito-borne disease.
RTS,S, which was developed in partnership with the PATH Malaria Vaccine Initiative (MVI), is the first candidate vaccine for the prevention of malaria to reach this milestone.
CENEVRE (CyHAN)- World Health Organization (WHO) announced Friday that a major milestone for malaria vaccine development has been achieved.
THE world's first malaria vaccine has been given the green light by regulators.
These children's chances of a full and healthy life may soon be transformed by the first malaria vaccine to prove its worth in full clinical trials.
ISLAMABAD -- The worlds first viable malaria vaccine may soon be able to help fight the disease, after final trial results confirmed its potential to prevent millions of cases of the deadly disease every year.
Tuesday, GlaxoSmithKline released results of an ongoing trial which show that the company's malaria vaccine is effective for about 18 months, cutting clinical malaria by 46 percent among young children compared to a control group.